Clinical trial

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

NCT04810104

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-10-01

PhasePHASE2

Study timeline

Study start (estimated)2022-10-01Date precision: month

Registry last updated2022-10-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Mild Cognitive Impairmentunresolved

Interventions

Sponsors & collaborators

King's College Londonlead sponsor

Helse Stavanger HFcollaborator

Michael J. Fox Foundation for Parkinson's Researchcollaborator

Parkinson's UKcollaborator

AstraZenecacollaborator

Masaryk Universitycollaborator

Norges Parkinsonforbund, Norwaycollaborator

University of Exetercollaborator

Stichting Lygaturecollaborator

Innovative Medicines Initiativecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04810104 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.